Condition

Recurrent or Metastatic Solid Tumors clinical trials and research

• 2Clinical trials
• 19Countries

All recruiting trials (2)

• Subcutaneous trastuzumab deruxtecan plus hyaluronidase for metastatic solid tumors

  This trial tests whether a subcutaneous form of trastuzumab deruxtecan given with hyaluronidase is safe and works for adults with recurrent or metastatic solid tumors.

  Recruiting at 26 sites Phase 1 Daiichi Sankyo · Newport Beach, California and 30 other locations · NCT07015697

• Evaluating Ifinatamab Deruxtecan for Recurrent or Metastatic Solid Tumors

  This study is testing a new drug called ifinatamab deruxtecan to see if it can help people with recurrent or metastatic solid tumors that have already been treated.

  Recruiting at 104 sites Phase 1/2 Daiichi Sankyo · Los Angeles, California and 119 other locations · NCT06330064

Related topics

Quick answers

How many Recurrent or Metastatic Solid Tumors clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 19 countries. The most sites are in Brazil (2 trials), France (2 trials), Japan (2 trials), Spain (2 trials), Taiwan (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →